[1]
|
Qiu, S., Miller, M.I., Joshi, P.S., et al. (2022) Multimodal Deep Learning for Alzheimer’s Disease Dementia As-sessment. Nature Communications, 13, Article No. 3404. https://doi.org/10.1038/s41467-022-31037-5
|
[2]
|
Jorfi, M., Maaser-Hecker, A. and Tanzi, R.E. (2023) The Neuroimmune Axis of Alzheimer’s Disease. Genome Medicine, 15, Article No. 6. https://doi.org/10.1186/s13073-023-01155-w
|
[3]
|
Tahami, M.A., Byrnes, M.J., White, L.A., et al. (2022) Alzheimer’s Disease: Epidemiology and Clinical Progression. Neurology and Therapy, 11, 553-569. https://doi.org/10.1007/s40120-022-00338-8
|
[4]
|
Chang, C.H., Lin, C.H. and Lane, H.Y. (2021) Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease. International Journal of Molecular Sciences, 22, Article 2761.
https://doi.org/10.3390/ijms22052761
|
[5]
|
Dubois, B., Villain, N., Frisoni, G.B., et al. (2021) Clinical Diag-nosis of Alzheimer’s Disease: Recommendations of the International Working Group. The Lancet Neurology, 20, 484-496.
https://doi.org/10.1016/S1474-4422(21)00066-1
|
[6]
|
Athar, T., Al, B.K. and Khan, S.A. (2021) Recent Ad-vances on Drug Development and Emerging Therapeutic Agents for Alzheimer’s Disease. Molecular Biology Re-ports, 48, 5629-5645. https://doi.org/10.1007/s11033-021-06512-9
|
[7]
|
Ling, T.S., Chandrasegaran, S., Xuan, L.Z., et al. (2021) The Potential Benefits of Nanotechnology in Treating Alzheimer’s Disease. BioMed Research International, 2021, Article ID: 5550938. https://doi.org/10.1155/2021/5550938
|
[8]
|
Hanslik, K.L. and Ul-land, T.K. (2020) The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer’s Disease. Frontiers in Neu-rology, 11, Article ID: 570711. https://doi.org/10.3389/fneur.2020.570711
|
[9]
|
Gerrits, E., Brouwer, N., Kooistra, S.M., et al. (2021) Distinct Amyloid-β and Tau-Associated Microglia Profiles in Alzheimer’s Disease. Acta Neuropathologica, 141, 681-696. https://doi.org/10.1007/s00401-021-02263-w
|
[10]
|
Huang, L., Peng, Y., Tao, X., et al. (2022) Microtubule Organization Is Essential for Maintaining Cellular Morphology and Function. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 1623181.
https://doi.org/10.1155/2022/1623181
|
[11]
|
Li, S., Wang, C., Wang, Z., et al. (2021) Involvement of Cere-brovascular Abnormalities in the Pathogenesis and Progression of Alzheimer’s Disease: An Adrenergic Approach. Aging, 13, 21791-21806.
https://doi.org/10.18632/aging.203482
|
[12]
|
Galea, I. (2021) The Blood-Brain Barrier in Systemic Infection and Inflammation. Cellular & Molecular Immunology, 18, 2489-2501. https://doi.org/10.1038/s41423-021-00757-x
|
[13]
|
Alahmari, A. (2021) Blood-Brain Barrier Overview: Struc-tural and Functional Correlation. Neural Plasticity, 2021, Article ID: 6564585. https://doi.org/10.1155/2021/6564585
|
[14]
|
Banwarth-Kuhn, M. and Sindi, S. (2020) How and Why to Build a Mathematical Model: A Case Study Using Prion Aggregation. Journal of Biological Chemistry, 295, 5022-5035. https://doi.org/10.1074/jbc.REV119.009851
|
[15]
|
Cesarino, I., Dello, I.R., Kirschner, G.K., et al. (2020) Plant Science’s Next Top Models. Annals of Botany, 126, 1-23.
https://doi.org/10.1093/aob/mcaa063
|
[16]
|
Chen, J., Liao, S., Xiao, Z., et al. (2022) The Development and Improvement of Immunodeficient Mice and Humanized Immune System Mouse Models. Frontiers in Immunology, 13, Article ID: 1007579.
https://doi.org/10.3389/fimmu.2022.1007579
|
[17]
|
盛哲津, 李利妹. 阿尔茨海默病动物模型的研究进展[J]. 实验动物与比较医学, 2022, 42(4): 342-350.
|
[18]
|
Ardanaz, C.G., Ramirez, M.J. and Solas, M. (2022) Brain Metabolic Alterations in Alzheimer’s Disease. International Journal of Molecular Sciences, 23, Article 3785. https://doi.org/10.3390/ijms23073785
|
[19]
|
Bai, B., Vanderwall, D., Li, Y., et al. (2021) Proteomic Landscape of Alzheimer’s Disease: Novel Insights into Pathogenesis and Biomarker Discovery. Molecular Neurodegeneration, 16, Article No. 55.
https://doi.org/10.1186/s13024-021-00474-z
|
[20]
|
Tracy, T.E., Madero-Perez, J., Swaney, D.L., et al. (2022) Tau Interactome Maps Synaptic and Mitochondrial Processes Associated with Neurodegeneration. Cell, 185, 712-728. https://doi.org/10.1016/j.cell.2021.12.041
|
[21]
|
Sarraf, S.A., Shah, H.V., Kanfer, G., et al. (2020) Loss of TAX1BP1-Directed Autophagy Results in Protein Aggregate Accumulation in the Brain. Molecular Cell, 80, 779-795. https://doi.org/10.1016/j.molcel.2020.10.041
|
[22]
|
Durkee, C., Kofuji, P., Navarrete, M., et al. (2021) Astrocyte and Neuron Cooperation in Long-Term Depression. Trends in Neurosciences, 44, 837-848. https://doi.org/10.1016/j.tins.2021.07.004
|
[23]
|
Mishra, R., Phan, T., Kumar, P., et al. (2022) Augmenting Neurogenesis Rescues Memory Impairments in Alzheimer’s Disease by Restoring the Memory-Storing Neurons. Journal of Experimental Medicine, 219, e20220391.
https://doi.org/10.1084/jem.20220391
|
[24]
|
Forner, S., Kawauchi, S., Balderrama-Gutierrez, G., et al. (2021) Systematic Phenotyping and Characterization of the 5xFAD Mouse Model of Alzheimer’s Disease. Scientific Data, 8, Article No. 270.
https://doi.org/10.1038/s41597-021-01054-y
|
[25]
|
Sanchez-Varo, R., Mejias-Ortega, M., Fernan-dez-Valenzuela, J.J., et al. (2022) Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis. In-ternational Journal of Molecular Sciences, 23, Article 5404.
https://doi.org/10.3390/ijms23105404
|
[26]
|
Lopez-Toledo, G., Silva-Lucero, M.D., Herrera-Diaz, J., et al. (2022) Patient-Derived Fibroblasts with Presenilin-1 Mutations, That Model Aspects of Alzheimer’s Disease Pa-thology, Constitute a Potential Object for Early Diagnosis. Frontiers in Aging Neuroscience, 14, Article ID: 921573.
|
[27]
|
Arber, C., Lovejoy, C., Harris, L., et al. (2021) Familial Alzheimer’s Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis. Cell Reports, 34, Article ID: 108615. https://doi.org/10.1016/j.celrep.2020.108615
|
[28]
|
Endres, K. (2021) Apolipoprotein A1, the Neglected Rela-tive of Apolipoprotein E and Its Potential role in Alzheimer’s Disease. Neural Regeneration Research, 16, 2141-2148. https://doi.org/10.4103/1673-5374.310669
|
[29]
|
Pires, M. and Rego, A.C. (2023) Apoe4 and Alzheimer’s Disease Pathogenesis-Mitochondrial Deregulation and Targeted Therapeutic Strategies. International Journal of Molecular Sciences, 24, Article 778.
https://doi.org/10.3390/ijms24010778
|
[30]
|
Sierksma, A., Lu, A., Mancuso, R., et al. (2020) Novel Alzheimer Risk Genes Determine the Microglia Response to Amyloid-β But Not to TAU Pathology. EMBO Molecular Medicine, 12, e10606.
https://doi.org/10.15252/emmm.201910606
|
[31]
|
Ittner, L.M., Klugmann, M. and Ke, Y.D. (2019) Adeno-Associated Virus-Based Alzheimer’s Disease Mouse Models and Potential New Therapeutic Avenues. British Journal of Pharmacology, 176, 3649-3665.
https://doi.org/10.1111/bph.14637
|
[32]
|
Sanchez-Hidalgo, A.C., Arias-Aragon, F., Romero-Barragan, M.T., et al. (2022) Selective Expression of the Neurexin Substrate for Presenilin in the Adult Forebrain Causes Deficits in Associative Memory and Presynaptic Plasticity. Experimental Neurology, 347, Article ID: 113896. https://doi.org/10.1016/j.expneurol.2021.113896
|
[33]
|
Hernandez-Sapiens, M.A., Reza-Zaldivar, E.E., Marquez-Aguirre, A.L., et al. (2022) Presenilin Mutations and Their Impact on Neuronal Differentiation in Alz-heimer’s Disease. Neural Regeneration Research, 17, 31-37.
https://doi.org/10.4103/1673-5374.313016
|
[34]
|
Pizzo, P., Basso, E., Filadi, R., et al. (2020) Presenilin-2 and Calcium Handling: Molecules, Organelles, Cells and Brain Networks. Cells, 9, Article 2166. https://doi.org/10.3390/cells9102166
|
[35]
|
Ledo, J.H., Liebmann, T., Zhang, R., et al. (2021) Presenilin 1 Phosphorylation Regulates Amyloid-Beta Degradation by Microglia. Molecular Psychiatry, 26, 5620-5635. https://doi.org/10.1038/s41380-020-0856-8
|
[36]
|
Galla, L., Redolfi, N., Pozzan, T., et al. (2020) Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2. International Journal of Molecular Sciences, 21, Article 770.
https://doi.org/10.3390/ijms21030770
|
[37]
|
Huang, D.X., Yu, X., Yu, W.J., et al. (2022) Calcium Signaling Regulated by Cellular Membrane Systems and Calcium Homeostasis Perturbed in Alzheimer’s Disease. Frontiers in Cell and Developmental Biology, 10, Article ID: 834962.
https://doi.org/10.3389/fcell.2022.834962
|
[38]
|
Mahan, T.E., Wang, C., Bao, X., et al. (2022) Selective Re-duction of Astrocyte apoE3 and apoE4 Strongly Reduces Aβ Accumulation and Plaque-Related Pathology in a Mouse Model of Amyloidosis. Mol Neurodegener, 17, Article No. 13. https://doi.org/10.1186/s13024-022-00516-0
|
[39]
|
Kothari, S., Bala, N., Patel, A.B., et al. (2021) The LDL Receptor Binding Domain of Apolipoprotein E Directs the Relative Orientation of Its C-Terminal Segment in Re-constituted Nascent HDL. Biochimica et Biophysica Acta, 1863, Article ID: 183618. https://doi.org/10.1016/j.bbamem.2021.183618
|
[40]
|
Tachibana, M., Holm, M.L., Liu, C.C., et al. (2019) APOE4-Mediated Amyloid-Beta Pathology Depends on Its Neuronal Receptor LRP1. Journal of Clinical Investi-gation, 129, 1272-1277. https://doi.org/10.1172/JCI124853
|
[41]
|
Okazawa, H. (2021) Intracellular Amyloid Hypothesis for Ultra-Early Phase Pathology of Alzheimer’s Disease. Neuropathology, 41, 93-98. https://doi.org/10.1111/neup.12738
|
[42]
|
Zhang, C., Xue, P., Zhang, H., et al. (2022) Gut Brain Interaction Theory Reveals Gut Microbiota Mediated Neurogenesis and Traditional Chinese Medicine Research Strategies. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 1072341. https://doi.org/10.3389/fcimb.2022.1072341
|
[43]
|
Zhang, H., Ben, Z.Y., Zhang, H., et al. (2021) Rho Signaling in Synaptic Plasticity, Memory, and Brain Disorders. Frontiers in Cell and Developmental Biology, 9, Article ID: 729076. https://doi.org/10.3389/fcell.2021.729076
|
[44]
|
Kolesnikova, T.O., Demin, K.A., Costa, F.V., et al. (2022) Towards Zebrafish Models of CNS Channelopathies. International Journal of Molecular Sciences, 23, Ar-ticle 13979. https://doi.org/10.3390/ijms232213979
|
[45]
|
Rosa, J., Lima, C. and Lopes-Ferreira, M. (2022) Zebrafish Larvae Behavior Models as a Tool for Drug Screenings and Pre-Clinical Trials: A Review. International Journal of Molecular Sciences, 23, Article 6647.
https://doi.org/10.3390/ijms23126647
|
[46]
|
Li, Y., Jia, Z., Zhang, S., et al. (2021) Progress in Gene-Editing Technology of Zebrafish. Biomolecules, 11, Article 1300. https://doi.org/10.3390/biom11091300
|
[47]
|
Shenoy, A., Banerjee, M., Upadhya, A., et al. (2022) The Brilliance of the Zebrafish Model: Perception on Behavior and Alzheimer’s Disease. Frontiers in Behavioral Neuroscience, 16, Article ID: 861155.
https://doi.org/10.3389/fnbeh.2022.861155
|
[48]
|
Saluja, D., Jhanji, R., Kaushal, S., et al. (2021) Importance of Zebrafish as an Efficient Research Model for the Screening of Novel Therapeutics in Neurological Disorders. CNS & Neurological Disorders, 20, 145-157.
https://doi.org/10.2174/1871527319666201207211927
|
[49]
|
James, D.M., Davidson, E.A., Yanes, J., et al. (2021) The Gut-Brain-Microbiome Axis and Its Link to Autism: Emerging Insights and the Potential of Zebrafish Models. Frontiers in Cell and Developmental Biology, 9, Article ID: 662916.
https://doi.org/10.3389/fcell.2021.662916
|
[50]
|
Espino-Saldana, A.E., Rodriguez-Ortiz, R., Pereida-Jaramillo, E., et al. (2020) Modeling Neuronal Diseases in Zebrafish in the Era of CRISPR. Current Neuropharmacology, 18, 136-152.
https://doi.org/10.2174/1570159X17666191001145550
|
[51]
|
Cosacak, M.I., Bhattarai, P., De Jager, P.L., et al. (2022) Single Cell/Nucleus Transcriptomics Comparison in Zebrafish and Humans Reveals Common and Distinct Molecular Responses to Alzheimer’s Disease. Cells, 11, Article 1807.
https://doi.org/10.3390/cells11111807
|
[52]
|
Disouky, A. and Lazarov, O. (2021) Adult Hippocampal Neuro-genesis in Alzheimer’s Disease. Progress in Molecular Biology and Translational Science, 177, 137-156. https://doi.org/10.1016/bs.pmbts.2020.09.002
|
[53]
|
Siddiqui, T., Bhattarai, P., Popova, S., et al. (2021) KYNA/Ahr Signaling Suppresses Neural Stem Cell Plasticity and Neurogenesis in Adult Zebrafish Model of Alz-heimer’s Disease. Cells, 10, Article 2748.
https://doi.org/10.3390/cells10102748
|
[54]
|
Bhattarai, P., Cosacak, M.I., Mashkaryan, V., et al. (2020) Neu-ron-Glia Interaction through Serotonin-BDNF-NGFR Axis Enables Regenerative Neurogenesis in Alzheimer’s Model of Adult Zebrafish Brain. PLOS BIOLOGY, 18, e3000585.
https://doi.org/10.1371/journal.pbio.3000585
|
[55]
|
Lee, J.G., Cho, H.J., Jeong, Y.M., et al. (2021) Genetic Approaches Using Zebrafish to Study the Microbiota-Gut-Brain Axis in Neurological Disorders. Cells, 10, Article 566. https://doi.org/10.3390/cells10030566
|
[56]
|
Murray, E.R., Kemp, M. and Nguyen, T.T. (2022) The Mi-crobiota-Gut-Brain Axis in Alzheimer’s Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions. Archives of Clinical Neuropsychology, 37, 595-607.
https://doi.org/10.1093/arclin/acac008
|
[57]
|
Zhang, H., Jiang, X., Ma, L., et al. (2022) Role of Abeta in Alz-heimer’s-Related Synaptic Dysfunction. Frontiers in Cell and Developmental Biology, 10, Article ID: 964075. https://doi.org/10.3389/fcell.2022.964075
|
[58]
|
Kotova, M.M., Galstyan, D.S., Kolesnikova, T.O., et al. (2023) Understanding CNS Effects of Antimicrobial Drugs Using Zebrafish Models. Veterinary Sciences, 10, Article 96. https://doi.org/10.3390/vetsci10020096
|
[59]
|
Nakamura, T., Fujiwara, K., Saitou, M., et al. (2021) Non-Human Primates as a Model for Human Development. Stem Cell Reports, 16, 1093-1103. https://doi.org/10.1016/j.stemcr.2021.03.021
|
[60]
|
李乙江, 肖文娴, 赵玲, 等. 灵长类动物在人类神经系统疾病动物模型中的应用[J]. 生物化学与生物物理进展, 2022, 49(5): 849-857.
|
[61]
|
Tramacere, A. and Iriki, A. (2021) A Novel Mind-Set in Primate Experimentation: Implications for Primate Welfare. Animal Models and Ex-perimental Medicine, 4, 343-350. https://doi.org/10.1002/ame2.12190
|
[62]
|
Alqot, H.E. and Rylett, R.J. (2023) A Novel Transgenic Mouse Model Expressing Primate-Specific Nuclear Choline Acetyltransferase: Insights into Potential Cholinergic Vulnerability. Scientific Reports, 13, Article No. 3037.
https://doi.org/10.1038/s41598-023-30155-4
|
[63]
|
Perez-Cruz, C. and Rodriguez-Callejas, J.D. (2023) The Common Marmoset as a Model of Neurodegeneration. Trends in Neurosciences, 46, 394-409. https://doi.org/10.1016/j.tins.2023.02.002
|
[64]
|
Philippens, I. and Langermans, J. (2021) Preclinical Marmoset Model for Targeting Chronic Inflammation as a Strategy to Prevent Alzheimer’s Disease. Vaccines, 9, Article 388. https://doi.org/10.3390/vaccines9040388
|